---
figid: PMC6192166__BMRI2018-9836256.003
figtitle: Proteomics and phosphoproteomics driven identification of the aberrant regulation
  of signalling pathways leading to poor patient survival
organisms:
- NA
pmcid: PMC6192166
filename: BMRI2018-9836256.003.jpg
figlink: /pmc/articles/PMC6192166/figure/fig3/
number: F3
caption: Proteomics and phosphoproteomics driven identification of the aberrant regulation
  of signalling pathways leading to poor patient survival. (a) Aberrant PDGFRB signalling
  pathway induces angiogenesis in patients and results in poor survival. Phosphorylated
  and unphosphorylated forms of proteins are indicated by blue and orange color. The
  directions of arrows indicate the regulation—up and down arrows indicate upregulation
  and downregulation, respectively. Colors of the arrows indicate the phosphoform
  or the total protein detected by (phospho)proteomics experiments. Blue and red arrows
  indicate phospho- and total protein, respectively. (b) Integrin-linked kinase pathway
  induces cell mobility and invasion, leading to poor patient survival. Two signalling
  pathways, MAPK (green) and PI3K (purple), are highlighted. Both these pathways were
  found to be upregulated in cancer patients with poor survival.
papertitle: 'Onco-Multi-OMICS Approach: A New Frontier in Cancer Research.'
reftext: Sajib Chakraborty, et al. Biomed Res Int. 2018;2018:9836256.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8644042
figid_alias: PMC6192166__F3
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC6192166__F3
ndex: bbcae77c-dee7-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6192166__BMRI2018-9836256.003.html
  '@type': Dataset
  description: Proteomics and phosphoproteomics driven identification of the aberrant
    regulation of signalling pathways leading to poor patient survival. (a) Aberrant
    PDGFRB signalling pathway induces angiogenesis in patients and results in poor
    survival. Phosphorylated and unphosphorylated forms of proteins are indicated
    by blue and orange color. The directions of arrows indicate the regulation—up
    and down arrows indicate upregulation and downregulation, respectively. Colors
    of the arrows indicate the phosphoform or the total protein detected by (phospho)proteomics
    experiments. Blue and red arrows indicate phospho- and total protein, respectively.
    (b) Integrin-linked kinase pathway induces cell mobility and invasion, leading
    to poor patient survival. Two signalling pathways, MAPK (green) and PI3K (purple),
    are highlighted. Both these pathways were found to be upregulated in cancer patients
    with poor survival.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PDGFRB
  - SHC1
  - GRB2
  - PIK3R1
  - PLCG1
  - SOS1
  - JAK1
  - JAK2
  - EIF2AK2
  - RASA1
  - SYNGAP1
  - PRKCB
  - PRKCA
  - STAT3
  - STAT1
  - HRAS
  - RAF1
  - RNASE3
  - MAP3K1
  - MAPK3
  - STAT6
  - MAP2K4
  - MAP2K1
  - SRF
  - FOS
  - FOSB
  - FOSL1
  - FOSL2
  - ELK1
  - KCNH4
  - KCNH8
  - JUN
  - JUNB
  - JUND
  - MAPK8
  - RAPGEF1
  - MAPK10
  - CRK
  - SORBS1
  - BCAR1
  - RBL2
  - NOLC1
  - RAB3GAP1
  - CSE1L
  - CTNND1
  - TMX2-CTNND1
  - DOCK1
  - ZYX
  - TNS1
  - ITGA1
  - ITGA10
  - ITGA11
  - ITGA2
  - ITGA2B
  - ITGA3
  - ITGA4
  - ITGA5
  - ITGA6
  - ITGA7
  - ITGA8
  - ITGA9
  - ITGAD
  - ITGAE
  - ITGAL
  - ITGAM
  - ITGAV
  - ITGAX
  - SRC
  - FGR
  - FYN
  - YES1
  - VASP
  - ARHGEF7
  - CSK
  - GIT2
  - ACTN1
  - ACTN2
  - ACTN3
  - ACTN4
  - VCL
  - ITGB1
  - ITGB2
  - ITGB3
  - ITGB4
  - ITGB5
  - ITGB6
  - ITGB7
  - ITGB8
  - ITGBL1
  - PAK1
  - PAK2
  - PAK3
  - PAK4
  - PAK5
  - PAK6
  - TLN1
  - PXN
  - PXDN
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - ILK
  - VAV2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R2
  - RAC2
  - CAPNS1
  - CAPN1
  - CAPN10
  - CAPN11
  - CAPN12
  - CAPN13
  - CAPN14
  - CAPN2
  - CAPN3
  - CAPN5
  - CAPN6
  - CAPN7
  - CAPN9
  - CAPN15
  - CAPN8
  - PTK2
  - RAC3
  - NCOA3
  - AKT1
  - CUX1
  - SART3
  - AKT2
  - AKT3
  - SHC3
  - MYPN
  - MYLK2
  - MAP2K7
  - MAP2K2
  - ZHX2
  - ARAF
  - BRAF
  - MAPK1
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK9
  - EPHB2
  - RHO
  - RHOD
  - RHOA
  - RHOB
  - RHOC
  - Cancer
  - Cardiomyopathy
---
